Finance

Beta
Lists
382150:KOSDAQ
OncoCross Co Ltd
₩4,700.00
+1.08%
(+50.00) 1D
Jun 10, 3:30:22 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 382150...
Open
₩4,565
High
₩4,790
Low
₩4,285
Mkt. cap
57.32B
Avg. vol.
141.38K
Volume
81.58K
52-wk high
₩14,490
52-wk low
₩4,285
EPS
-₩775
Shares outstanding
12.20M
No. of employees
31
Open
₩4,565
High
₩4,790
Low
₩4,285
Mkt. cap
57.32B
Avg. vol.
141.38K
Volume
81.58K
52-wk high
₩14,490
52-wk low
₩4,285
EPS
-₩775
Shares outstanding
12.20M
No. of employees
31
News stories
From sources across the web
About OncoCross Co Ltd
CEO-
Employees31
Founded2015
Headquarters-
SectorBiotechnology
Websiteoncocross.com
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
137.78M
29.18M
140.93M
167.27M
Cost of goods sold
14.73M
27.60M
-31.53M
7.45M
Cost of revenue
14.73M
27.60M
-31.53M
7.45M
Research and development expenses
574.37M
683.69M
854.17M
1.00B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.22B
1.38B
1.20B
1.34B
Operating expense
1.99B
2.37B
2.38B
2.67B
Total operating expenses
2.01B
2.39B
2.35B
2.68B
Operating income
-1.87B
-2.36B
-2.21B
-2.51B
Other non operating income
-400.00
372.51M
-510.43M
67.11M
EBT including unusual items
-1.76B
-2.04B
-2.87B
-2.63B
EBT excluding unusual items
-1.81B
-2.05B
-2.87B
-2.64B
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
25.13M
114.25M
28.49M
36.87M
Net income
-1.76B
-2.04B
-2.87B
-2.63B
Net profit margin
-1,277.00%
-7,006.19%
-2,036.86%
-1,574.90%
Earnings per share
-
-
-
-
Interest and investment income
66.58M
130.01M
160.61M
169.70M
Interest expense
-8.75M
-191.65M
-315.11M
-363.10M
Net interest expenses
57.83M
-61.63M
-154.50M
-193.40M
Depreciation and amortization charges
167.85M
185.05M
290.51M
289.81M
EBITDA
-1.70B
-2.17B
-1.92B
-2.22B
Gain or loss from assets sale
-36.00K
-31.33K
146.27K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer